Panel Discussion: Advancing Cell Therapy Manufacturing: Embracing AI, Automation and Digitalisation

Panel Discussion: Advancing Cell Therapy Manufacturing: Embracing AI, Automation and Digitalisation

Tuesday, March 17, 2026 5:10 PM to 6:10 PM · 1 hr. (Europe/London)
Cell Therapy Manufacturing Sponsored by MasterControl (Track 10)
Panel Discussion
Aldevron119Founded in 1998, Aldevron is a global leader in enabling the development of next-generation genomic medicines. As part of Danaher Corporation (NYSE: DHR) family of global science and technology companies, Aldevron empowers scientists and innovators worldwide to advance transformative therapies that are redefining the future of medicine. Aldevron’s expertise and integrated solutions have supported landmark achievements—including playing a key role in manufacturing the world’s first mRNA-based personalized CRISPR therapy. With facilities in Fargo, ND, Madison, WI and Waltham, MA, Aldevron is at the forefront of accelerating scientific discovery and expanding the possibilities of gene editing, gene therapy and other breakthrough modalities. By partnering with leading researchers and organizations, Aldevron is helping to turn the promise of genomic medicine into reality for patients around the globe.

Log in

See all the content and easy-to-use features by logging in or registering!